Royalty Pharma (RPRX) Treasury Shares (2019 - 2026)

Royalty Pharma has disclosed Treasury Shares across 8 years of filings, most recently posting $2.7 million for Q2 2026.

• In Q2 2026, Treasury Shares rose 4.29% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $2.7 million (up 4.29% YoY), while the FY2025 annual figure was $2.6 million, down 1.88% from the prior year.
• Treasury Shares came in at $2.7 million for Q2 2026 at Royalty Pharma, up from $2.7 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2023 to a low of $2.6 million in Q3 2025.
• Average Treasury Shares over 5 years is $2.7 million, with a median of $2.7 million recorded in 2024.
• Year-over-year, Treasury Shares advanced 15.98% in 2022 and slipped 6.31% in 2023.
• Over 5 years, Treasury Shares stood at $2.8 million in 2022, then decreased by 6.31% to $2.6 million in 2023, then increased by 1.26% to $2.7 million in 2024, then retreated by 1.88% to $2.6 million in 2025, then rose by 4.29% to $2.7 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $2.7 million in Q2 2026, $2.7 million in Q1 2026, and $2.6 million in Q4 2025.